China Universal Asset Management Co., Ltd. Silverback Therapeutics, Inc. Transaction History

China Universal Asset Management Co., Ltd.

  • $1.03 Billion
  • Q4 2024

A detailed history of China Universal Asset Management Co., Ltd. transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 20,607 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,607
Previous 18,645 10.52%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025
BUY
N/A
1,962 Added 10.52%
20,607 $0
Q3 2024

Oct 25, 2024
BUY
N/A
7,262 Added 63.8%
18,645 $0
Q2 2024

Jul 19, 2024
SELL
N/A
-7,070 Reduced 38.31%
11,383 $0
Q1 2024

Apr 29, 2024
BUY
N/A
7,348 Added 66.17%
18,453 $189,000
Q4 2023

May 21, 2024
SELL
N/A
-7,348 Reduced 39.82%
11,105 $0
Q4 2023

Jan 23, 2024
BUY
N/A
8,652 Added 352.71%
11,105 $61,000
Q3 2023

May 21, 2024
BUY
N/A
1,211 Added 97.5%
2,453 $0
Q3 2023

Oct 30, 2023
BUY
N/A
1,211 Added 97.5%
2,453 $9,000
Q2 2023

May 21, 2024
SELL
N/A
-28 Reduced 2.2%
1,242 $0
Q2 2023

Jul 27, 2023
SELL
N/A
-28 Reduced 2.2%
1,242 $8,000
Q1 2023

May 21, 2024
BUY
N/A
317 Added 33.26%
1,270 $0
Q1 2023

Apr 27, 2023
BUY
N/A
317 Added 33.26%
1,270 $8,000
Q4 2022

May 21, 2024
SELL
$0.0 - $6.07 $0 - $106,225
-17,500 Reduced 94.84%
953 $0
Q4 2022

Jan 31, 2023
BUY
$0.0 - $6.07 $0 - $3,769
621 Added 187.05%
953 $8,000
Q3 2022

Oct 21, 2022
BUY
$3.91 - $5.52 $1,298 - $1,832
332 New
332 $2,000

Others Institutions Holding SBTX

# of Institutions
170
Shares Held
64.3M
Call Options Held
842K
Put Options Held
589K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email